Transplantation of muscle precursor cells (MPCs) is a promising approach for the treatment of muscular dystrophies. However, preclinical and clinical results have shown that the technology is not yet efficient enough for most therapeutic applications. Among the problems that remain unsolved are low cellular survival, poor proliferation and lack of migration of the transplanted cells. One major technical hurdle for the optimization of transplantation protocols is how to follow precisely the fate of the cells after transplantation. In this study, we examined the use of a secreted form of the mouse alkaline phosphatase (mSeAP) enzyme as the reporter system transduced into MPCs using a retroviral vector. We show that circulating mSeAP could be detected in the serum of the transplanted mice at different time points after MPC transplantation. We also found that the level of circulating mSeAP is highly correlated with the number of transplanted cells and that mSeAP is an excellent histological marker. Further, studying the levels of circulating mSeAP compared with the number of muscle fibers positive to mSeAP and to dystrophin, enabled detailed analyses of bottleneck steps for successful transplantation. Taken together, our results show that mSeAP is an excellent quantitative 'real-time' reporter gene for cell therapy preclinical studies.
Introduction
Although differentiated skeletal muscle fibers are postmitotic, adult muscle has a remarkable capacity for regeneration. This regeneration is derived largely from the muscle satellite cells, which are quiescent cells located under the basal lamina of muscle fibers. 1 Transplantation of muscle precursor cells (MPCs) into degenerating muscle is an experimental therapeutic approach for muscle pathologies such as muscular dystrophies. 2, 3 MPCs that are used for transplantation may be derived in tissue culture from satellite cells. Such MPCs can undergo terminal differentiation into myotubes in vitro, and if implanted into suitable sites in host mice, are capable of forming de novo muscle fibers or integrating into the host muscle fibers. 4 The MPCs for muscle transplantation could be derived from a normal donor or, in cases of defined genetic pathologies, could be 'self' cells corrected by using gene therapy strategies. However, at present, the MPC transplantation approach has a number of limitations, including poor survival and limited proliferation and migration capacity in the host muscle. 2, 3 One of the major technical problems at present in the preclinical studies is the lack of a good way to monitor the fate of the transplanted cells. Among the methods used earlier for this purpose, we can cite the use of GFP, LacZ and luciferase (as reporter genes), the immunostaining for dystrophin expression in the cases of dystrophin deficiencies, 5 and analysis with quantitative PCR of Y chromosome expression by male cells transplanted in the female host. 6 All these methods provided partial solutions to the study of survival, evolution and fate of the transplanted cells. In a new approach, we wished to evaluate the potential of using a secreted reporter gene derived from a natural murine alkaline phosphatase enzyme as a tracker in protocols of MPC transplantation. The use of the human placental alkaline phosphatase gene (PLAP) enzyme as a reporter gene was initially reported by Cullen et al. 7 who derived from the natural enzyme a secreted form that was used for quantification experiments in cell culture, whereas the first in vivo use in the mouse was reported by Bettan et al. 8 A further improvement for application in experiments with mice was achieved by Wang et al., 9 which cloned and derived the secreted form of the mouse embryonic alkaline phosphatase (mSeAP). This version of the reporter gene avoids immune response in experiments on mice against the transgenic protein. 10 As a model system we have focused on the dystrophindeficient mdx mouse, which is a classical model for MPC transplantation. The most common way to detect the contribution of transplanted cells from the normal donor into the muscle of the mdx host is immunostaining for dystrophin expression. This method gives a good indication at the end point of the experiment about the number of regenerating fibers that integrated donor cells. However, this technique requires killing the host mouse for the analysis and does not provide quantitative measurement of the survival of the transplanted cells. A quantitative method to analyze MPC survival is a quantitative PCR measurement of Y chromosome expression by the male donor MPC transplanted in the female muscle. 11 Besides being technically not easy and of limited accuracy, this method suffers from an inherited disadvantage of the development of immune response in the female host against the male minor histocompatibility HY antigen expressed in donor cells, as was shown by Boulanger et al. 12 The use of mSeAP as a reporter gene presents several advantages. First, the lack of an immune response against mSeAP (unlike lacZ, Luciferase and the Y-chromosome). Second, its thermostability compared with the endogenous phosphatases expressed in the adult allows its specific detection in an easy and highly sensitive assay with a low background. Third, the use of a secreted protein allows not only its detection in serum samples in a real-time manner but also the analysis at multiple time points throughout the entire experimental period. Fourth, the small amounts of mSeAP that remain in the producer cells allow a sensitive in situ detection of the transplanted cells. In addition to confirm all the above advantages in the context of MPCs transplantation, here we have studied the correlations between the level of circulating mSeAP, the number of fibers positive for mSeAP, and the expression of dystrophin in regenerating fibers. Our results confirm the high potential of using mSeAP in preclinical transplantation studies and therefore open the way for future applications.
Results and discussion

Preparation and characterization of transplanted cells
Mouse MPCs were obtained from muscle biopsy of 3-day-old male C57Bl/6 mice. This initial culture, designated MyoB6-M2, was amplified and enriched by a protocol of quick trypsinization followed by short preplating, for cells of myoblast morphology during passages 1-5. At this stage the culture was characterized and found to contain 491% desmin and 84% SM/C-2.6 positive cells, both being myogenic markers. 13, 14 In addition, the MyoB6-M2 cells were found to be 38% ScaI positive and negative to the CD45 (hematopoietic), CD31 (endothelial) and CD34 (stem cell) antigenic markers (data not shown). The myogenic nature of the MyoB6-M2 culture has been further confirmed by incubating the cells in muscle differentiation media, which resulted after 5 days in an efficient myotube formation (not shown). MyoB6-M2 cells were then transduced by an MLV-mSeAP viral vector to obtain the B6M2-mSeAP culture. Enzymatic staining for alkaline phosphatase (AP) activity confirmed transgene expression in 92% of the cells in proliferation and in both mono-nucleated cells and myotubes in differentiated culture. In addition, secretion of mSeAP into the medium was confirmed in both conditions ( Figure 1 and data not shown). We have found excellent correlation between the number of cells in the dish and the production of mSeAP (Figure 1 ), qualifying secreted mSeAP as a good indicator of the number of mSeAP-producing cells.
Evaluation of the in vitro and in vivo half-life of the mSeAP protein
An mSeAP-enriched medium was produced by the incubation of non-confluent MLV-mSeAP-transduced MyoB6-M2 culture in the proliferation medium. To test mSeAP stability, the conditioned medium was added into either an empty flask or into a flask containing non-infected MyoB6-M2, at standard culture incubation conditions. Medium samples were analyzed for AP activity during 11 days. The level of mSeAP dropped slowly during the 11 days with a similar kinetic in the empty flask and the flask containing the non-infected MyoB6-M2 (Figure 2a ). In vitro half-life time was calculated to be between 10 and 11 days and was not influenced by the presence of the cells. To measure the half-life time of mSeAP in vivo, we intravenously transfused mice with mSeAP-enriched mouse serum. The level of mSeAP in the first blood sample, obtained only 15 min after transfusion, indicated that almost all the injected mSeAP was still present in the circulation at this time point. However, a sharp drop to less than half of this value was observed within 24-h and trace amounts could be detected 6 days later (Figure 2b ). These results show that despite its extreme in vitro stability, mSeAP is quickly eliminated in vivo, with a calculated half-life time of about 18-h. On account of this short half-life, mSeAP analysis in the serum allows an almost real-time monitoring of its production in vivo. Together, the in vitro and in vivo studies of the stability Figure 1 Correlation between the number of infected cells and the production of mSeAP. Mouse muscle precursor cells (MPCs) were prepared from hind limb muscle tissues derived from a 3-day-old male C57Bl/6 mouse as described. 15 mSeAP cDNA obtained from Vincent Thuiller 9 was cloned into an MLV plasmid backbone under the control of the viral LTR promoter, to give the MLV-mSeAP viral vector. Production of the viral vector with a VSV-g envelop was carried out by standard transient transfection in 293-T cells. MyoB6-M2 cells were infected to give the B6M2-mSeAP cells. Triplicate tissue culture plates were plated with increasing amounts of B6M2-mSeAP cells. Six hours after plating, the medium was replaced with a fresh one, which was conditioned for 2-h and then analyzed for mSeAP content. As a negative control, we analyzed the medium from plates with the non-infected MyoB6-M2 cells, or without cells, and obtained values of mSeAPo1 ng ml -1 . Alkaline phosphatase (AP) assay was carried out with the Phospha-Light kit (Tropix, Applied Biosystems, Bedford, MA, USA) following the manufacturer's instruction. Luminescence reactions were analyzed with a Victor luminometer (Walac/Perkin-Elmer, Waltham, MA, USA). 16 This experiment showed the utility of the mSeAP technology as a 'real-time' quantitative reporter for the detection of survival of the transplanted MPCs.
Correlation between serum mSeAP and MPC integration in host muscle
A histological study was carried out in the transplanted TA muscle post mortem at 28 days after transplantation, to evaluate the correlation between the level of circulating mSeAP and the survival and differentiation of the transplanted cells. In our system, the expression of transgenic AP in the transplanted cells was controlled by the ubiquitous LTR viral promoter whereas the expression of the endogenous dystrophin gene was controlled by its natural promoter and therefore activated only in To assay the stability of mSeAP in vivo, mice were transfused intravenously (100 ml/mouse, n ¼ 2) with mouse serum highly enriched for mSeAP (20 mg ml -1 ), derived from a donor mouse, which had been injected intramuscularly with an AAV-mSeAP viral vector (provided by Genethon's AAV group (Genethon, Evry, France)). The AAV-mSeAP viral vector encodes for an mSeAP protein, which is identical to the mSeAP produced by the MLVmSeAP. Both donor and transfused mice were male C57Bl/6. mSeAP was detected in the blood of the transfused mice one day before transfusion as a negative control (mSeAP ¼ 2 ng ml -1 ), at 15 min, and at days 1, 2, 6 and 12 after transfusion. The level of mSeAP at 12 days was equivalent to that of the negative control. Real-time monitoring of cell transplantation in mouse muscle X Gerard et al differentiated MPCs inside the myofibers. Thus, the overall survival of the transplanted B6M2-mSeAP cells is indicated by staining for AP activity whereas dystrophin staining indicates myofiber integration and differentiation of transplanted MPCs. Despite this difference in the control of expression, the overall staining pattern of AP and dystrophin showed high overlapping (Figures 4c  and d) , indicating that indeed mSeAP and dystrophin were expressed in the same cells and that many of the transplanted cells integrated in the regenerating fibers and differentiated correctly to express dystrophin. In a marked exception, some rare dystrophin fibers in small clusters (Figure 4e ) did not express mSeAP (Figure 4f ), suggesting that these are revertant fibers. 17 Thus, in situ expression of mSeAP, which highly overlaps with dystrophin expression, further supports the potential of mSeAP as a reporter for in vivo tracking of grafted cells.
Particularly valuble in the context of dystrophinopathies, mSeAP staining permitted the important distinction between the expression of dystrophin in revertant fibers and expression in fibers integrating transplanted MPCs. Twenty-eight days after transplantation we have found a good correlation between the dose of transplanted cells and the level of circulating mSeAP (R ¼ 0.99), and to a lesser extent, correlation with the number of fibers positive to mSeAP (R ¼ 0.94) and to dystrophin (R ¼ 0.78). The augmentation in the level of circulating mSeAP retarded slightly behind the increase in the dose of transplanted cells between the third (450 000 cells) and the fourth (1450 000 cells) groups. The augmentation in the number of fibers positive for mSeAP retarded further, between these two mice groups (absence of significant augmentation, PX0.2), whereas unexpectedly, no increase at all in the number of dystrophin-positive fibers was found between the third (184 ± 34) and the fourth groups (182±21.5) ( Figure 5 and Table 1 ). The slow down between the third and fourth groups in the augmentation in the number of mSeAP-positive fibers compared with the level of circulating mSeAP may reflect a reduction in the rate diffusion and integration of MPC into the fibers. The lack of augmentation in the number of fibers positive to dystrophin reflect the reduced differentiation capacity B6M2-mSeAP cells (n ¼ 4/group). Mice were killed 28 days after transplantation and the TA muscles were removed for analysis as described in Figure 4 . Note that circulating mSeAP values reflect the total number of surviving-transplanted cells, some of which may escape from the muscle, the number of fibers positive for mSeAP staining is proportional to the number of transplanted-surviving cells inside the muscle, both differentiated and non-differentiated, and the number of dystrophin-positive fibers is proportional to the number of transplanted-surviving cells, which were integrated in fibers and underwent myogenic differentiation. All microscopic images and analyses were carried out on a morphometric analysis working station (Microvision, France) composed of a Nikon microscope (Eclipse E600) equipped with a motorized plate and a digital CCD (Sony) camera. Fibers were counted in representative transversal sections from the middle part of the injected muscles. The number of dystrophin (182±21.5) and mSeAP (308±52.5) positive fibers in the group of mice transplanted by 1 350 000 cells is on the limit of significant difference (P ¼ 0.057), whereas, no significant difference (PX0.2) was found between the number of mSeAP fibers in the third and fourth mice groups.
Real-time monitoring of cell transplantation in mouse muscle X Gerard et al of the transplanted MPCs between these two groups. These results suggest that the three different detection methods used here, namely the level of circulating mSeAP, mSeAP expression in fibers and dystrophin expression in fibers, provided, respectively, complementary information about survival, diffusion and integration, and differentiation of the transplanted MPC, hence permits better overall interpretation of the results of the transplantation experiment.
Conclusion
The data obtained after the transplantation of mSeAPexpressing MPCs into dystrophic mdx mice, including the circulating and cell-associated mSeAP and the dystrophin expression, provide an occasion for a detailed quantitative analysis of the bottleneck steps during the procedure of MPC transplantation, starting by cell injection until the expression of dystrophin in the corrected fibers. Such a fine analysis of this sequence of events was not possible until now. Altogether, our results show that the mSeAP-based reporter method presented here provides a new quantitative, sensitive and powerful tool for real-time monitoring of cell transplantation. Finally, cell labeling by retrovirally-transduced mSeAP might be used in a broader context of cell-grafting experiments demanding cell monitoring. The values in Table 1 are presented graphically in Figure 5 . Statistical analysis: data are means ± s.e.m. Wilcoxon signed-rank test was applied to analyse significance of the data. a Coefficient of correlation between the different doses of transplanted cells and the measured parameter.
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